REPORT HIGHLIGHT
The neurology devices market was valued at USD XX billion by 2019, growing with XX% CAGR during the forecast period, 2020-2026.
Market Dynamics
Neurology devices are medical devices that helps to prevent, diagnose, and treat a variety of neurological conditions and disorders such as Parkinson's disease, Alzheimer's disease, traumatic brain injury, and depression. Neurology device can be used to help in restoring eyesight and hearing. This medical device provides improved function for those with congenital differences or limb loss. Moreover, the procedure volumes in treatment of aneurysms is on a rise owing to the improved early detection and aging demographics. According to Who, the neurological disorders all access the globe is increasing at a swift pace, which will create huge investment opportunities in the neurology devices market.
The growth of neurology devices market is being driven by the increasing development of neurosurgical endoscopy devices and growing advancements in imaging technologies. This is majorly due to the increased spending on healthcare infrastructure and R&D activities, and growing foreign direct investment by leading manufacturers. Growing geriatric population all over the globe is likely to have a vital impact on the market growth. As life expectancy endures to increase, neurological disorders such as Alzheimer's disease and dementia will become more pervasive. Further, the rising number of projects related to neuroinformatics for providing algorithms are also significant factors predicted to gear the demand for neurology devices. However, high costs associated with neurology devices and in treatment for neurological disorders in the emerging economies will hamper the growth of global market for neurology devices.
Product Takeaway
Based on products, the global market has been segmented into interventional neurology, neurosurgery devices, CSF management, and neurostimulation. Further, the neurostimulation devices are categorized into gastric stimulation, nerve stimulation, and spinal cord stimulation. The neurostimulation devices segment is anticipated to hold largest market share during the forecast period. This is mainly due to the growing incidences of chronic nervous disorders all over the globe. On the other hand, the neurosurgery devices segment is expected to register profitable growth by the end of 2026. This is majorly due to increased usage of this devices by the neurosurgeons. To evade occurrence of hospital acquired infections, the Patient Protection and Affordable Care Act is encouraging the surgeons to utilize high value medical devices.
Neurosurgery segment including stereotactic systems, ultrasonic aspirators, aneurysm clips, and neuroendoscopes are projected to witness substantial growth throughout the period of forecast. This is mainly due to their vital nature of use in repair surgeries of brain cell damage and tumour removal.
In June 2017, the FDA approved VNS (Vagus Nerve Stimulation) Therapy Programming System of LivaNova. This VNS program system of marginally invasive treatment is impacting the neurostimulation segment as it is designed to prevent seizures in young patients less than four years of age with refractory partial-onset seizures. A few months later, the England-based company received approval for its SenTiva implantable device and next-generation VNS device for drug-resistant epilepsy.
Regional Takeaway
Geographically, the global market for neurology devices is classified into North America, Asia Pacific, Europe, LATAM, and MEA. North America region is projected to dominate the market during the forecast period owing to the surge in prevalence of neurological diseases such as Parkinson and Alzheimer's disease. The well-developed healthcare infrastructure, rise in government funds for R&D activities, and presence of leading players in this region are some other factors uplifting the growth of North America neurology devices industry.
On the other hand, the Asia Pacific neurology devices market is predicted to rise at a CAGR of XX% from 2020 to 2026. Rising medical expenditure in developing economies such as China & India, and rapidly growing healthcare R&D investment coupled with high-unmet medical needs are the primary factors fuelling the growth in this region.
Key Vendor Takeaway
Some of the major players that are actively involved in the growth of neurology devices industry include B. BraunMelsungen AG, Covidien PLC, Integra LifeSciences Holdings Corp., Johnson & Johnson, Medtronic Inc., Magstim Co Ltd., Stryker Corp., W.L. Gore & Associates Inc., and St. Jude Medical Inc. These players are adopting several strategies such as mergers & acquisitions, R&D activities, and product development to enhance their presence in the global neurology devices market.
For instance, in February 2017, Integra LifeSciences Holdings Corporation proclaimed that it has made a binding offer to Johnson & Johnson for acquiring their Codman Neurosurgery business for a cash value of $1.045 billion. The Codman Neurosurgery offers a range of devices focused on advanced operative surgery, neuro-critical care, and hydrocephalus. The acquisition was finalized later in October 2017, by which Integra enhanced its position as a leading neurosurgical provider all over the globe.
The market size and forecast for each segment and sub-segments has been considered as below:
Historical Year - 2015 to 2018
Base Year - 2019
Estimated Year - 2020
Projected Year - 2026
TARGET AUDIENCE
Traders, Distributors, and Suppliers
Manufacturers
Government and Regional Agencies
Research Organizations
Consultants
Distributors
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
KEY PLAYERS
BraunMelsungen AG
Covidien PLC
Boston Scientific Corporation
Integra LifeSciences Holdings Corp.
Johnson & Johnson
Medtronic Inc.
Magstim Co Ltd.
Stryker Corp.
L. Gore & Associates Inc.
Jude Medical Inc.
MARKET BY PRODUCT
Neurostimulation
Deep Brain Stimulation
Spinal Cord Stimulation
Sacral Nerve Stimulation
Gastric Electric Stimulation
Vagus Nerve Stimulation
Neurovascular Catheters
Micro Guidewires
Micro Catheters
Interventional Neurology
Embolic Coils
Aneurysm Coiling and Embolization
Liquid Embolic Reagents
Flow Diversion Devices
Cerebral Balloon Angioplasty & Stents
Balloon Occlusion Devices
Filter Devices
Carotid Artery Stents
Neurosurgery Devices
Stereotactic Systems
Ultrasonic Aspirators
Aneurysm Clips
Neuroendoscopes
CSF Management Devices
Cerebral External Drainage
Cerebral Shunts
Neurothromobectomy
Snare Devices
Suction Aspiration Devices
Clot Retrievers
MARKET BY REGION
North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Singapore
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Rest of LATAM
Middle East and Africa
Saudi Arabia
United Arab Emirates
Rest of MEA
TABLE OF CONTENT
1. NEUROLOGY DEVICES MARKET OVERVIEW
- 1.1. Study Scope
- 1.2. Assumption and Methodology
2. EXECUTIVE SUMMARY
- 2.1. Market Snippet
- 2.1.1. Market Snippet by Product
- 2.1.2. Market Snippet by Region
- 2.1.3. Competitive Insights
3. NEUROLOGY KEY MARKET TRENDS
- 3.1. Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
- 3.2. Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
- 3.3. Market Opportunities
- 3.4. Market Future Trends
4. NEUROLOGY DEVICES INDUSTRY STUDY
- 4.1. Porter's Five Forces Analysis
- 4.2. Marketing Strategy Analysis
- 4.3. Growth Prospect Mapping
- 4.4. Regulatory Framework Analysis
5. NEUROLOGY DEVICES MARKET LANDSCAPE
- 5.1. Market Share Analysis
- 5.2. Key Innovators
- 5.3. Breakdown Data, by Key manufacturer
- 5.3.1. Established Player Analysis
- 5.3.2. Emerging Player Analysis
6. NEUROLOGY DEVICES MARKET - BY PRODUCT
- 6.1. Overview
- 6.1.1. Segment Share Analysis, By Product, 2019 & 2026 (%)
- 6.2. Neurostimulation
- 6.2.1. Overview
- 6.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
- 6.2.3. Deep Brain Stimulation
- 6.2.3.1. Overview
- 6.2.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
- 6.2.4. Spinal Cord Stimulation
- 6.2.4.1. Overview
- 6.2.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
- 6.2.5. Sacral Nerve Stimulation
- 6.2.5.1. Overview
- 6.2.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
- 6.2.6. Gastric Nerve Stimulation
- 6.2.6.1. Overview
- 6.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
- 6.2.7. Vagus Nerve Stimulation
- 6.2.7.1. Overview
- 6.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
- 6.3. Neurovascular Catheters
- 6.3.1. Overview
- 6.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
- 6.3.3. Micro Guidewires
- 6.3.3.1. Overview
- 6.3.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
- 6.3.4. Micro Catheters
- 6.3.4.1. Overview
- 6.3.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
- 6.4. Interventional Neurology
- 6.4.1. Overview
- 6.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
- 6.4.3. Embolic Coils
- 6.4.3.1. Overview
- 6.4.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
- 6.4.4. Aneurysm Coiling and Embolization
- 6.4.4.1. Overview
- 6.4.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
- 6.4.5. Liquid Embolic Reagents
- 6.4.5.1. Overview
- 6.4.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
- 6.4.6. Flow Diversion Devices
- 6.4.6.1. Overview
- 6.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
- 6.5. Cerebral Balloon Angioplasty & Stents
- 6.5.1. Overview
- 6.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
- 6.5.3. Balloon Occlusion Devices
- 6.5.3.1. Overview
- 6.5.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
- 6.5.4. Filter Devices
- 6.5.4.1. Overview
- 6.5.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
- 6.5.5. Carotid Artery Stents
- 6.5.5.1. Overview
- 6.5.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
- 6.6. Neurosurgery Devices
- 6.6.1. Overview
- 6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
- 6.6.3. Stereotactic Systems
- 6.6.3.1. Overview
- 6.6.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
- 6.6.4. Ultrasonic Aspirators
- 6.6.4.1. Overview
- 6.6.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
- 6.6.5. Aneurysm Clips
- 6.6.5.1. Overview
- 6.6.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
- 6.6.6. Neuroendoscopes
- 6.6.6.1. Overview
- 6.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
- 6.7. CSF Management Devices
- 6.7.1. Overview
- 6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
- 6.7.3. Cerebral External Drainage
- 6.7.3.1. Overview
- 6.7.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
- 6.7.4. Cerebral Shunts
- 6.7.4.1. Overview
- 6.7.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
- 6.8. Neurothromobectomy
- 6.8.1. Overview
- 6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 -2026, (US$ Million)
- 6.8.3. Snare Devices
- 6.8.3.1. Overview
- 6.8.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
- 6.8.4. Suction Aspiration Devices
- 6.8.4.1. Overview
- 6.8.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
- 6.8.5. Clot Retrievers
- 6.8.5.1. Overview
- 6.8.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
7. NEUROLOGY DEVICES MARKET- BY GEOGRAPHY
- 7.1. Introduction
- 7.1.1. Segment Share Analysis, By Region, 2019 & 2026 (%)
- 7.2. North America
- 7.2.1. Overview
- 7.2.2. Key Manufacturers in North America
- 7.2.3. North America Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)
- 7.2.4. North America Market Size and Forecast, By Product, 2015 - 2026 (US$ Million)
- 7.2.5. U.S.
- 7.2.5.1. Overview
- 7.2.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
- 7.2.6. Canada
- 7.2.6.1. Overview
- 7.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
- 7.3. Europe
- 7.3.1. Overview
- 7.3.2. Key Manufacturers in Europe
- 7.3.3. Europe Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)
- 7.3.4. Europe Market Size and Forecast, By Product, 2015 - 2026 (US$ Million)
- 7.3.5. Germany
- 7.3.5.1. Overview
- 7.3.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
- 7.3.6. Italy
- 7.3.6.1. Overview
- 7.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
- 7.3.7. United Kingdom
- 7.3.7.1. Overview
- 7.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
- 7.3.8. France
- 7.3.8.1. Overview
- 7.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
- 7.3.9. Rest of Europe
- 7.3.9.1. Overview
- 7.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
- 7.4. Asia Pacific (APAC)
- 7.4.1. Overview
- 7.4.2. Key Manufacturers in Asia Pacific
- 7.4.3. Asia Pacific Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)
- 7.4.4. Asia Pacific Market Size and Forecast, By Product, 2015 - 2026 (US$ Million)
- 7.4.5. India
- 7.4.5.1. Overview
- 7.4.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
- 7.4.6. China
- 7.4.6.1. Overview
- 7.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
- 7.4.7. Japan
- 7.4.7.1. Overview
- 7.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
- 7.4.8. South Korea
- 7.4.8.1. Overview
- 7.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
- 7.4.9. Rest of APAC
- 7.4.9.1. Overview
- 7.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
- 7.5. Latin America
- 7.5.1. Overview
- 7.5.2. Key Manufacturers in Latin America
- 7.5.3. Latin America Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)
- 7.5.4. Latin America Market Size and Forecast, By Product, 2015 - 2026 (US$ Million)
- 7.5.5. Brazil
- 7.5.5.1. Overview
- 7.5.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
- 7.5.6. Mexico
- 7.5.6.1. Overview
- 7.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
- 7.5.7. Argentina
- 7.5.7.1. Overview
- 7.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
- 7.5.8. Rest of LATAM
- 7.5.8.1. Overview
- 7.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
- 7.6. Middle East and Africa
- 7.6.1. Overview
- 7.6.2. Key Manufacturers in Middle East and Africa
- 7.6.3. Middle East and Africa Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)
- 7.6.4. Middle East and Africa Market Size and Forecast, By Product, 2015 - 2026 (US$ Million)
- 7.6.5. Saudi Arabia
- 7.6.5.1. Overview
- 7.6.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
- 7.6.6. United Arab Emirates
- 7.6.6.1. Overview
- 7.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
8. KEY VENDOR ANALYSIS
- 8.1. B.BraunMelsungen AG
- 8.1.1. Company Snapshot
- 8.1.2. Financial Performance
- 8.1.3. Product Benchmarking
- 8.1.4. Strategic Initiatives
- 8.2. Covidien PLC
- 8.3. Boston Scientific Corporation
- 8.4. Integra LifeSciences Holdings Corp.
- 8.5. Johnson & Johnson
- 8.6. Medtronic Inc.
- 8.7. Magstim Co. Ltd.
- 8.8. Stryker Corp.
- 8.9. W. L. Gore & Associates Inc.
- 8.10. St. Jude Medical Inc.
9. 360 DEGREE ANALYSTVIEW
10. APPENDIX
- 10.1. Research Methodology
- 10.2. References
- 10.3. Abbreviations
- 10.4. Disclaimer
- 10.5. Contact Us
比較リスト
